Shanghai Xihua Scientific Co.,Ltd.(Xihua) was established in 2015. The headquarters is located in the core area of the Pharmaceutical Valley in Zhangjiang Hi-Tech Park, Shanghai. We have subsidiaries Xihua Pharmaceuticals, Xihua PharmaTech, Xihua Clinical , Suzhou Xihua , Chuzhou Xihua, etc. Besides, Xihua holds Primera Analytical Solutions Corp.(U.S.) and TCM Groups (U.S.) as well. With drug testing as the core, Xihua provides global pharmaceutical companies with high quality and efficient full process and integrated services from self-medicated development to market approval.
Xihua scientific provides professional bioanalytical services, including method development, method validation, sample analysis, long-term sample storage, and consulting services for Large-molecule biopharmaceuticals, small-molecule chemical drugs and biomarkers. As of 2022.06.30, we have passed over 110 times of NMPA on-site inspection and 20 times exempt from inspection, five consecutive years passed External Quality Assessment(EQA) from the National Health Commission and 2022 CNAS certification. The core members, with experience in bioanalytical departments of world-renowned pharmaceutical companies and CROs, are well versed in both domestic and international bioanalytical regulations and quality systems. Meanwhile, our team is experienced in passing inspections of NMPA, FDA, OECD and EMA, and all verified items were accepted by Chinese and Western medical and drug administrations. Xihua has been certified as a Shanghai High-tech Enterprise, one of the Little Giants Companies, has won the honorary title of excellent enterprise in the growth group of the biomedical industry in the 8th China Innovation & Entrepreneurship Competition national final.
Development and Validation of Large and Small Molecule Drugs and Biomarkers
Long-term Sample Storage
Building 5, 6, 7, Lane 118, Furong Hua Road, Pudong New Area, Shanghai